Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

A significant decrease in rectal volume and diameter during prostate IMRT.

Anderson NS, Yu JB, Peschel RE, Decker RH.

Radiother Oncol. 2011 Feb;98(2):187-91. doi: 10.1016/j.radonc.2010.12.005. Epub 2011 Jan 25.

PMID:
21269715
2.

Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.

Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M.

Radiat Oncol. 2006 Sep 6;1:34.

3.

Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.

Guckenberger M, Pohl F, Baier K, Meyer J, Koelbl O, Flentje M, Vordermark D.

Strahlenther Onkol. 2006 Dec;182(12):721-6.

PMID:
17149579
4.

Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Bohrer M, Schröder P, Welzel G, Wertz H, Lohr F, Wenz F, Mai SK.

Strahlenther Onkol. 2008 Dec;184(12):674-8. doi: 10.1007/s00066-008-1837-z. Epub 2008 Dec 24.

PMID:
19107349
5.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
6.

Optimization of collimator parameters to reduce rectal dose in intensity-modulated prostate treatment planning.

Chapek J, Tobler M, Toy BJ, Lee CM, Leavitt DD.

Med Dosim. 2005 Winter;30(4):205-12.

PMID:
16275562
7.

[Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer].

Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.

Cancer Radiother. 2004 Apr;8(2):59-69. English, French.

PMID:
15063872
8.

Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.

Teh BS, Dong L, McGary JE, Mai WY, Grant W 3rd, Butler EB.

Med Dosim. 2005 Spring;30(1):25-30.

PMID:
15749008
9.

Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.

Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.

Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.

PMID:
18215434
10.

Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.

Hysing LB, Skorpen TN, Alber M, Fjellsbø LB, Helle SI, Muren LP.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1496-503. doi: 10.1016/j.ijrobp.2008.04.011. Epub 2008 Jun 4.

PMID:
18538493
11.

IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.

van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):291-303.

PMID:
16618584
12.

Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.

Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1146-50. Epub 2007 Oct 24.

PMID:
17919834
13.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
14.

Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer.

Guckenberger M, Pohl F, Baier K, Meyer J, Vordermark D, Flentje M.

Radiother Oncol. 2006 Apr;79(1):59-64. Epub 2006 Apr 3.

PMID:
16584794
15.

Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.

Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9.

PMID:
16111582
16.

Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?

Sanguineti G, Cavey ML, Endres EJ, Franzone P, Barra S, Parker BC, Marcenaro M, Colman M, Agostinelli S, Foppiano F, Vitale V.

Strahlenther Onkol. 2006 Sep;182(9):543-9.

PMID:
16944377
17.

Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?

Guckenberger M, Baier K, Richter A, Vordermark D, Flentje M.

Radiat Oncol. 2008 Jan 11;3:3. doi: 10.1186/1748-717X-3-3.

18.

Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?

Garipagaoglu M, Sengoz M, Senkesen O, Ozan Göksel E, Tezcanli E, Kucucuk H, Aslay I.

J BUON. 2010 Oct-Dec;15(4):668-73.

PMID:
21229627
19.

Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?

Sanguineti G, Cavey ML, Endres EJ, Brandon GG, Bayouth JE.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):151-60. Epub 2005 Sep 28.

PMID:
16198066
20.

Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.

De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):639-48.

PMID:
10837946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk